← Leaderboards
C Fernando D Oliveira
Venatorx Pharmaceuticals, Inc.
$185,161
Attributed
$185,161
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$185,161 · 1
By mechanism
N01$185,161 · 1
Top collaborators
No co-investigators on record.
Most similar at Venatorx Pharmaceuticals, Inc.
Same institution · by research overlap
- Luigi Xerri$39,662,982
- Timothy Henkel$48,583,055
- Denis Marc Daigle$7,512,530
- Daniel Pevear$25,064,821
- Steven Armen Boyd$13,685,544
Others in their field
Other Rising Stars on “Advanced Development”
- Kiran Datta · Leidos Biomedical Research, Inc.$277,585,346
- Katherine M Thibault · Battelle Memorial Institute$134,148,552
- Mari Ostendorf · University Of Washington$51,931,230
- Richard Smith · Medical Device Innovation Consortium$41,401,350
- Brian Zavertnik · Palantir Technologies, Inc.$33,059,912
- Cyrus Wadia · Activate Global, Inc.$31,489,493
Research focus
Advanced DevelopmentAntibiotic ResistanceBacterial Drug ResistanceBacterial ResistanceBiodefenseCandidate SelectionChemistryClinical AssessmentsCombating Antibiotic Resistant BacteriaCommunicable DiseasesEfficacy EvaluationEmerging Communicable DiseasesLead OptimizationManufacturePathogenPre-ClinicalProduct DevelopmentResearch And DevelopmentResearch SupportSafety AssessmentTherapeutic CandidateTherapeutic Development